Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 1766713019 | Glyburide + metformin (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1778294018 | Glyburide + metformin | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 3490608018 | Product containing glibenclamide and metformin hydrochloride (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 3494795012 | Product containing glibenclamide and metformin hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| 3494796013 | Product containing glyburide and metformin hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Product containing precisely glibenclamide 1.25 milligram and metformin hydrochloride 250 milligram/1 each conventional release oral tablet | Is a | False | Product containing glibenclamide and metformin hydrochloride | Inferred relationship | Existential restriction modifier | |
| Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet | Is a | False | Product containing glibenclamide and metformin hydrochloride | Inferred relationship | Existential restriction modifier | |
| Product containing precisely glibenclamide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet | Is a | False | Product containing glibenclamide and metformin hydrochloride | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets